Abstract

ORGAN-TRANSPLANT recipients are prone to the development of cutaneous and extracutaneous malignant tumors.1 , 2 Lymphomas occur in 1 to 2 percent of graft recipients and are usually of the B-cell type.3 Cutaneous T-cell lymphomas are extremely rare. We describe a renal-transplant recipient with multiple cutaneous warts and squamous-cell carcinomas in whom a cutaneous T-cell lymphoma (Sezary syndrome) later developed, followed by a nodal B-cell lymphoma with immunoblastic components. Despite chemotherapy, the cutaneous T-cell lymphoma progressed rapidly, and the patient died within a year of the diagnosis. This case illustrates the role of immunosuppression in the development of multiple and complex malignant . . .

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.